Key Organics July Newsletter, issue 11

CAMELFORD, U.K. - July 17, 2015 - PRLog -- In this issue:

We announce the continued expansion of the BIONET portfolio with co-marketing agreements with Cancer Research Technology (Ximbio (http://www.ximb.io/)) to promote tool compounds from the various Principal Investigators in Oncology and Liverpool ChiroChem who have a very interesting range of chiral amines which should prove to be useful in Research.
BIONET also releases a range of new 5-trifluoromethyl-2,3-disubstituted pyridines, key intermediates for the Agrochemical and Pharma Industries.
We describe how Key Organics has synthesised Risperidone-d4 and how we can help with your Isotopically Labelled Compound requirements.
Features the 2nd Generation BIONET Premium Fragment Library which is now available.
DABAL-Me3 - a versatile tool for modern chemistry and now part of the BIONET collection, a result of our collaboration with the University of Nottingham.
Profile our event attendance at conferences and exhibitions this quarter.

http://www.keyorganics.net/wp-content/uploads/2015/07/ko_newsQ3_Jul2015.pdf